# To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH.

> **NCT02962674** · NA · TERMINATED · sponsor: **ProstaCare Singapore Pte. Ltd.** · enrollment: 49 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DEVICE:** prostaFix System

## Key facts

- **NCT ID:** NCT02962674
- **Lead sponsor:** ProstaCare Singapore Pte. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09-19
- **Primary completion:** 2018-10-30
- **Final completion:** 2020-11-20
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2021-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02962674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02962674, "To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02962674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*